Stockreport

Marinus (MRNS) Down 83% on Lead Drug Falling Short in Seizure Study [Yahoo! Finance]

Marinus Pharmaceuticals, Inc.  (MRNS) 
Last marinus pharmaceuticals, inc. earnings: 11/6 07:30 am Check Earnings Report
US:NASDAQ Investor Relations: ir.marinuspharma.com/investor-relations
PDF RAISE study evaluating lead drug ganaxolone in refractory status epilepticus (RSE). The RAISE study, which evaluated an intravenous (IV) formulation of ganaxolone, did [Read more]